Literature DB >> 9375273

Renovascular hypertension.

C V Ram1.   

Abstract

In the vast population of patients with established hypertension, there is a small group in whom the blood pressure elevation is caused by renal ischemia. These patients have renovascular hypertension, which can presently be diagnosed with greater precision than in the past. The exact prevalence of renovascular hypertension is not known and the diagnosis is probably missed in many patients. It is important to recognize this condition in clinical practice, because it is a correctable from of secondary hypertension and because it is a reversible cause of renal failure in some patients. Clinical identification of patients with renovascular hypertension has been so imprecise and complex that the very diagnostic quest for this condition has been questioned. However, it is well recognized that renovascular disease is a progressive disorder with serious sequelae if appropriate therapy is not rendered.

Entities:  

Mesh:

Year:  1997        PMID: 9375273     DOI: 10.1097/00041552-199711000-00014

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  7 in total

1.  Long-term safety and efficacy of renin-angiotensin blockade in atherosclerotic renal artery stenosis.

Authors:  Sofia Sofroniadou; Theodoros Kassimatis; Rajaventhan Srirajaskanthan; John Reidy; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2011-11-30       Impact factor: 2.370

Review 2.  Atherosclerotic renal artery stenosis--diagnosis and treatment.

Authors:  David Lao; Punit S Parasher; Kerry C Cho; Yerem Yeghiazarians
Journal:  Mayo Clin Proc       Date:  2011-07       Impact factor: 7.616

3.  Sonographic assessment of kidneys in patients with hypertension co-existed with diabetes mellitus and ischemic heart disease.

Authors:  Moawia Gameraddin; Walaa Ismail Musa; Suzan Abdelmaboud; Sultan Alshoabi; Kamal Dahan Alsultan; Bushra A Abdelmalik
Journal:  J Family Med Prim Care       Date:  2020-05-31

4.  Stenting and medical therapy for atherosclerotic renal-artery stenosis.

Authors:  Christopher J Cooper; Timothy P Murphy; Donald E Cutlip; Kenneth Jamerson; William Henrich; Diane M Reid; David J Cohen; Alan H Matsumoto; Michael Steffes; Michael R Jaff; Martin R Prince; Eldrin F Lewis; Katherine R Tuttle; Joseph I Shapiro; John H Rundback; Joseph M Massaro; Ralph B D'Agostino; Lance D Dworkin
Journal:  N Engl J Med       Date:  2013-11-18       Impact factor: 91.245

5.  Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis.

Authors:  Christopher A Drummond; Pamela S Brewster; Wencan He; Kaili Ren; Yanmei Xie; Katherine R Tuttle; Steven T Haller; Kenneth Jamerson; Lance D Dworkin; Donald E Cutlip; Timothy P Murphy; Ralph B D'Agostino; William L Henrich; Jiang Tian; Joseph I Shapiro; Christopher J Cooper
Journal:  PLoS One       Date:  2017-03-17       Impact factor: 3.240

6.  Effects of percutaneous angioplasty on kidney function and blood pressure in patients with atherosclerotic renal artery stenosis.

Authors:  Suhyun Kim; Mi Jeoung Kim; Jeunseok Jeon; Hye Ryoun Jang; Kwang Bo Park; Wooseong Huh; Young Soo Do; Yoon-Goo Kim; Dae Joong Kim; Ha Young Oh; Jung Eun Lee
Journal:  Kidney Res Clin Pract       Date:  2019-09-30

7.  Renal Fibrosis Is Significantly Attenuated Following Targeted Disruption of Cd40 in Experimental Renal Ischemia.

Authors:  Shungang Zhang; Joshua D Breidenbach; Fatimah K Khalaf; Prabhatchandra R Dube; Chrysan J Mohammed; Apurva Lad; Stanislaw Stepkowski; Terry D Hinds; Sivarajan Kumarasamy; Andrew Kleinhenz; Jiang Tian; Deepak Malhotra; David J Kennedy; Christopher J Cooper; Steven T Haller
Journal:  J Am Heart Assoc       Date:  2020-03-21       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.